Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

89.45 

0.00 0.0%

as of Mar 19 '19

52 Week Range:

60.60 93.96


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; and products for surgical treatment of tumors or vascular diseases, such as aneurysms. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Equity (BVPS) 9.59
10.01
10.16
11.22
10.39
10.67
15.79
16.39
growth rate 4.4% 1.5% 10.4% -3.8% 2.7% 48.0% 3.8%
Earnings BIT 131.90
119.75
129.32
152.89
172.57
growth rate -9.2% 8.0% 18.2% 12.9%
Avg.PE 35.39
28.49
33.03
49.60
growth rate -19.5% 15.9% 50.2%
ROA 7.65
6.88
6.88
7.83
7.85
9.62
7.42
5.72
8.24
9.37
7.70
growth rate -10.1% 0.0% 13.8% 0.3% 22.6% -22.9% -22.9% 44.1% 13.7% -17.8%
ROE 11.26
10.02
10.04
11.42
11.46
13.82
10.60
8.48
12.67
13.36
10.08
growth rate -11.0% 0.2% 13.8% 0.4% 20.6% -23.3% -20.0% 49.4% 5.5% -24.6%
ROIC 9.97
9.75
9.72
11.47
11.40
13.46
10.36
8.36
12.50
13.18
10.02
growth rate -2.2% -0.3% 18.0% -0.6% 18.1% -23.0% -19.3% 49.5% 5.4% -24.0%
Cur. Ratio 3.48
3.49
3.48
3.72
3.32
3.55
3.48
3.19
3.00
3.82
4.47
growth rate 0.3% -0.3% 6.9% -10.8% 6.9% -2.0% -8.3% -6.0% 27.3% 17.0%
Quick Ratio 2.57
2.73
2.69
2.88
2.64
2.77
2.52
2.31
2.17
2.95
3.48
growth rate 6.2% -1.5% 7.1% -8.3% 4.9% -9.0% -8.3% -6.1% 35.9% 18.0%
Leverage 1.47
1.45
1.47
1.45
1.47
1.40
1.45
1.51
1.56
1.34
1.28
growth rate -1.4% 1.4% -1.4% 1.4% -4.8% 3.6% 4.1% 3.3% -14.1% -4.5%
Balance Sheet Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Acct.Receivable 429.00
428.77
392.60
450.10
626.29
934.98
growth rate -0.1% -8.4% 14.7% 39.2% 49.3%
Acct.Payable 37.00
55.69
49.95
66.31
86.53
100.46
growth rate 50.5% -10.3% 32.8% 30.5% 16.1%
Cur.Assets 709.00
735.46
695.86
776.30
858.83
1,207.89
growth rate 3.7% -5.4% 11.6% 10.6% 40.6%
Total Assets 963.00
983.07
1,039.11
1,139.29
1,247.73
1,623.11
growth rate 2.1% 5.7% 9.6% 9.5% 30.1%
Cash 10.00
6.29
10.73
13.04
8.71
3.93
growth rate -37.1% 70.7% 21.6% -33.2% -54.9%
Inventory 143.00
148.47
172.40
189.41
208.31
234.30
growth rate 3.8% 16.1% 9.9% 10.0% 12.5%
Cur.Liabilities 214.00
207.24
200.08
243.39
285.90
316.08
growth rate -3.2% -3.5% 21.6% 17.5% 10.6%
Liabilities 267.00
267.76
284.88
341.84
396.57
381.37
growth rate 0.3% 6.4% 20.0% 16.0% -3.8%
LT Debt 2.00
1.82
1.59
0.92
2.00
growth rate -9.0% -12.8% -42.3% 118.3%
Equity 715.27
753.86
797.84
1,215.38
growth rate 5.4% 5.8% 52.3%
Common Shares 81.00
81.00
81.00
81.00
81.00
81.00
81.00
81.00
81.00
86.00
89.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 6.2% 3.5%
Cash Flow Statement Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Capital Expenditures 15.00
9.72
11.14
9.77
12.80
13.66
growth rate -35.2% 14.6% -12.3% 31.0% 6.7%
Cash Dividends 36.59
32.52
30.90
37.57
growth rate -11.1% -5.0% 21.6%
Cash From OA 92.00
64.62
63.11
56.74
111.77
37.73
growth rate -29.8% -2.4% -10.1% 97.0% -66.2%
FCF per Share 0.90
0.52
1.18
0.72
0.25
1.50
0.52
1.03
growth rate -42.2% 126.9% -39.0% -41.1% 500.0% -65.3% 98.1%
Sale Purchase of Stock 315.04
315.04
315.04
315.04
growth rate 0.0% 0.0% 0.0%
FCF 42.00
71.00
54.00
31.00
67.00
54.00
45.00
40.00
84.00
-1.00
152.00
growth rate 69.1% -23.9% -42.6% 116.1% -19.4% -16.7% -11.1% 110.0% -100.0% 100.0%
Income Statement Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Sales 862.00
906.45
909.26
1,040.06
1,088.37
1,189.90
growth rate 5.2% 0.3% 14.4% 4.6% 9.3%
Op.Income 76.00
131.90
119.75
129.32
152.89
172.57
growth rate 73.6% -9.2% 8.0% 18.2% 12.9%
IBT 114.54
101.72
141.96
188.56
growth rate -11.2% 39.6% 32.8%
Net Income 76.00
92.13
74.95
62.30
98.33
134.45
growth rate 21.2% -18.6% -16.9% 57.8% 36.7%
EPS 0.66
0.62
0.68
0.82
0.88
1.13
0.92
0.77
1.21
1.57
1.41
growth rate -6.1% 9.7% 20.6% 7.3% 28.4% -18.6% -16.3% 57.1% 29.8% -10.2%
Gross Profit 461.00
487.46
488.37
539.68
579.55
656.73
growth rate 5.7% 0.2% 10.5% 7.4% 13.3%
R&D 99.75
111.96
123.41
145.79
growth rate 12.2% 10.2% 18.1%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 38.70
49.21
46.36
47.90
growth rate 27.2% -5.8% 1.7%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 915.66
growth rate
Acct.Payable 83.65
growth rate
Cur.Assets 1,199.98
growth rate
Total Assets 1,603.19
growth rate
Cash 5.65
growth rate
Inventory 247.48
growth rate
Cur.Liabilities 254.64
growth rate
Liabilities 321.39
growth rate
LT Debt
growth rate
Equity 1,215.38
1,260.05
1,260.05
1,293.46
growth rate 3.7% 0.0% 1.3%
Common Shares 89.44
growth rate
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures
growth rate
Cash From OA
growth rate
FCF
growth rate
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 294.70
318.95
312.60
323.60
growth rate 8.2% -2.0% 1.7%
Op.Income 38.70
49.21
46.36
47.90
47.90
growth rate 27.2% -5.8% 3.3% 0.0%
IBT 38.50
45.52
36.76
41.40
41.40
growth rate 18.2% -19.3% 12.6% 0.0%
Net Income 28.50
27.57
25.87
28.70
growth rate -3.3% -6.2% 5.3%
Gross Profit 162.90
172.33
172.63
177.50
growth rate 5.8% 0.2% 1.4%
R&D 40.20
39.80
39.99
37.70
37.70
growth rate -1.0% 0.5% -5.7% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (51.50)

YOY Growth Grade:

E (28.90)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 54.43 54.31 23.15
EPS / Growth -18.2% 1.65 19.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 32.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 17.6% 17.6%
Future PE 2.00 37.62 37.62
Future EPS 1.82 8.36 8.36
Value Price
MOS %
0.90
-99.0%
77.75
-13.1%
77.75
-13.1%
MOS Price 0.45 38.87 38.87
IRT 43.24 13.60 13.60

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.